Back to 
Rafferty Asset Management, LLC
Rafferty Asset Management, LLC
XERS
14 quarters
Position history for Rafferty Asset Management, LLC's holdings in Xeris Biopharma Holdings, Inc.
Yes. Rafferty Asset Management holds 22,889 shares of XERS, worth $181,281, as of its Q2 2026 13F filing. It reduced the position by 1,358 shares (-5.6%) from Q1 2026. Rafferty Asset Management has held XERS since Q1 2024, across 10 quarterly 13F filings.
Current Value
$181,281
Current Shares
22,889
Total Value Change
+$54,281
Total Shares Change
-20,452
Quarter-by-Quarter History
Other major holders of XERS: BlackRock, Inc., Vanguard Group Inc.